| Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19 (NCT05541510) | Advagene Biopharma Co. Ltd. | 2022-12-01 |
| Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC (NCT05534113) | The First Affiliated Hospital with Nanjing Medical University | 2022-12-01 |
| CKD-702 Plus Irinotecan in Gastric Cancer (NCT05750290) | National Cancer Center, Korea | 2022-12-01 |
| A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF (NCT03925194) | Heidelberg University | 2022-12-01 |
| Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer (NCT05669807) | Zhejiang Cancer Hospital | 2022-12-01 |
| Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer (NCT05643677) | Fujian Medical University | 2022-12-01 |
| A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis (NCT05359393) | Fudan University | 2022-12-01 |
| Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial (NCT07039318) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2022-12-01 |
| KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis (NCT06342960) | Kyverna Therapeutics | 2022-12-01 |
| Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC (NCT05668767) | Beijing Chest Hospital | 2022-12-01 |
| Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus (NCT05646693) | University of Guadalajara | 2022-12-01 |
| Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole (NCT05163106) | University Hospital, Akershus | 2022-12-01 |
| Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer (NCT05595889) | Fujian Cancer Hospital | 2022-12-01 |
| CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma (NCT05613348) | Zhujiang Hospital | 2022-12-01 |
| Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder (NCT06633315) | Maternal and Child Health Hospital of Hubei Province | 2022-12-01 |
| Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations. (NCT05754736) | The Second Affiliated Hospital of Shandong First Medical University | 2022-12-01 |
| Study of Bacopa in Gulf War Illness Patients (NCT04927338) | Nova Southeastern University | 2022-12-01 |
| D-serine AudRem: R33 Phase (NCT05046353) | New York State Psychiatric Institute | 2022-12-01 |
| Suvorexant for Opioid/Stimulant Co-use (NCT05546515) | Johns Hopkins University | 2022-12-01 |
| TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study (NCT05882370) | Fei Gao | 2022-12-01 |
| Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer (NCT05795296) | RenJi Hospital | 2022-12-01 |
| A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease (NCT05642442) | Jazz Pharmaceuticals | 2022-12-01 |
| Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma (NCT05659251) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-12-01 |
| A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer (NCT05641506) | Sichuan Cancer Hospital and Research Institute | 2022-12-01 |
| Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma (NCT05091372) | M.D. Anderson Cancer Center | 2022-12-01 |
| Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade (NCT05265962) | The First Affiliated Hospital of Zhengzhou University | 2022-12-01 |
| Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults (NCT05269459) | University of Nebraska | 2022-12-01 |
| Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS) (NCT05418010) | Queen Mary University of London | 2022-12-01 |
| Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant (NCT04312789) | Ayman Saad | 2022-12-01 |
| Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19 (NCT05365321) | Andrei Carvalho Sposito | 2022-12-01 |
| A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC) (NCT05618691) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2022-12-01 |
| Rescue Progesterone Supplementation During Frozen Embryo Transfer (NCT05555121) | Clinique Ovo | 2022-12-01 |
| Atorvastatin in Patients With Ulcerative Colitis (NCT05561062) | Tanta University | 2022-12-01 |
| Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia (NCT05608928) | Tropical Gastroenterology & Nutrition Group (TROPGAN) | 2022-12-01 |
| A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation (NCT03422705) | University of Leeds | 2022-12-01 |
| Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment (NCT05738317) | Xiaorong Dong | 2022-12-01 |
| The Phase Ⅱ/Ⅲ Trial of LYB001 (NCT05602558) | Yantai Patronus Biotech Co., Ltd. | 2022-12-01 |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 (NCT05695508) | University of Heidelberg Medical Center | 2022-12-01 |
| RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial (NCT04105270) | Masonic Cancer Center, University of Minnesota | 2022-11-30 |
| A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors (NCT05741242) | Jaime Leandro Foundation for Therapeutic Cancer Vaccines | 2022-11-30 |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) (NCT05642962) | Memorial Sloan Kettering Cancer Center | 2022-11-30 |
| A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder (NCT05594589) | Eisai Co., Ltd. | 2022-11-30 |
| Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman (NCT05627791) | Department of Medical Services Ministry of Public Health of Thailand | 2022-11-30 |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer (NCT05628038) | Fudan University | 2022-11-30 |
| Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy (NCT05858983) | Frontera Therapeutics | 2022-11-30 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension (NCT05678621) | Monash University | 2022-11-30 |
| Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus (NCT05306873) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-11-30 |
| Switch Maintenance in Pancreatic (NCT05419479) | James Cleary, MD, PhD | 2022-11-30 |
| Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide (NCT04694586) | University Hospital, Linkoeping | 2022-11-30 |
| Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 (NCT05387239) | Vitti Labs, LLC | 2022-11-30 |
| Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder (NCT05626959) | Fenix Innovation Group | 2022-11-30 |
| A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer (NCT05608044) | Agenus Inc. | 2022-11-30 |
| Polypill in Acute Coronary Syndrome (NCT05514938) | University of Texas Southwestern Medical Center | 2022-11-30 |
| Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients (NCT05596890) | Guangdong Provincial People's Hospital | 2022-11-30 |
| SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors (NCT05631262) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2022-11-30 |
| Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk (NCT05620771) | Northwestern University | 2022-11-30 |
| A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT05604885) | SynAct Pharma Aps | 2022-11-30 |
| PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer (NCT04243941) | UNC Lineberger Comprehensive Cancer Center | 2022-11-29 |
| Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer (NCT05659056) | The First Affiliated Hospital with Nanjing Medical University | 2022-11-29 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO (NCT05500508) | Aminex Therapeutics, Inc. | 2022-11-29 |
| BMS-986253 in Myelodysplastic Syndromes (NCT05148234) | National Cancer Institute (NCI) | 2022-11-29 |
| Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer (NCT05420584) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2022-11-29 |
| A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) (NCT05619692) | Supernus Pharmaceuticals, Inc. | 2022-11-29 |
| Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (NCT05688280) | Immunophotonics, Inc. | 2022-11-29 |
| A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (NCT05568706) | Enanta Pharmaceuticals, Inc | 2022-11-29 |
| 24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG (NCT05549219) | Glycomine, Inc. | 2022-11-29 |
| A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors (NCT05584670) | Sanofi | 2022-11-29 |
| Accelerated TMS in Psychosis (NCT05567848) | Beth Israel Deaconess Medical Center | 2022-11-29 |
| Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations (NCT05659914) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2022-11-28 |
| Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas (NCT05565417) | Immunitas Therapeutics | 2022-11-28 |
| Effect of Lithium Therapy on Long COVID Symptoms (NCT05618587) | State University of New York at Buffalo | 2022-11-28 |
| Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study (NCT05545150) | Northwestern University | 2022-11-28 |
| Colchicine Use in Intracranial Atherosclerotic Disease (NCT05503225) | Chinese University of Hong Kong | 2022-11-28 |
| A Study of ELX-02 in Patients With Alport Syndrome (NCT05448755) | Eloxx Pharmaceuticals, Inc. | 2022-11-28 |
| Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP) (NCT05577754) | Centre Hospitalier Universitaire Dijon | 2022-11-28 |
| Erector Spinae Plane Block Versus Caudal Epidural Analgesia (NCT06815094) | National Cancer Institute, Egypt | 2022-11-28 |
| Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) (NCT05551598) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2022-11-28 |
| Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD) (NCT05657691) | Actinogen Medical | 2022-11-28 |
| Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older (NCT05624606) | Sanofi Pasteur, a Sanofi Company | 2022-11-28 |
| Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age (NCT05630859) | GlaxoSmithKline | 2022-11-28 |
| Satisfaction With FreeStyle Libre 2 Monitoring Versus Capillary Blood Glucose Monitoring in People With DM2 (NCT06624553) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2022-11-28 |
| Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile (NCT05593042) | Pontificia Universidad Catolica de Chile | 2022-11-28 |
| Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations (NCT04992858) | Sunshine Lake Pharma Co., Ltd. | 2022-11-27 |
| Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants (NCT05340465) | University of Washington | 2022-11-27 |
| Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression (NCT06005870) | Huazhong University of Science and Technology | 2022-11-26 |
| An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision (NCT04646967) | Alberta Children's Hospital | 2022-11-25 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 (NCT05476887) | Kira Pharmacenticals (US), LLC. | 2022-11-25 |
| SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma (NCT05524168) | Sun Yat-sen University | 2022-11-25 |
| Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis (NCT05588843) | Sanofi | 2022-11-25 |
| Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery (NCT06204120) | Luye Pharma Group Ltd. | 2022-11-25 |
| Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine (NCT05846373) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2022-11-25 |
| Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies (NCT05611853) | BioNova Pharmaceuticals (Shanghai) LTD. | 2022-11-25 |
| NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial (NCT05569811) | SOLTI Breast Cancer Research Group | 2022-11-25 |
| AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer (NCT05430906) | Hunan Cancer Hospital | 2022-11-25 |
| Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC (NCT05781958) | Shen Feng | 2022-11-24 |
| A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events (NCT05563246) | Eli Lilly and Company | 2022-11-24 |
| CaffeinICU Study - A Study on Oral Caffeine in ICU Patients With Coma (NCT05232734) | Singapore General Hospital | 2022-11-24 |
| Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors (NCT06614140) | Seqker Biosciences, Inc. | 2022-11-24 |
| A Study of Hemay005 in Adult With Atopic Dermatitis (NCT05769946) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2022-11-24 |
| Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort (NCT05308888) | University Hospital, Brest | 2022-11-23 |